Article
High expression of UBD correlates with epirubicin resistance and indicates poor prognosis…
OncoTargets and Therapy · 2015 · Tao H, Liu Z, Li H, Xie W, Zhang R, Zhu L, Guo F, Han Y, Sheng Y, Xie X
Key facts
| Title | High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer |
|---|---|
| First author | Tao H, Liu Z, Li H, Xie W, Zhang R, Zhu L, Guo F, Han Y, Sheng Y, Xie X |
| Journal | OncoTargets and Therapy |
| Published | Jul 6, 2015 |
| DOI | 10.2147/OTT.S81214 |
| Product codes mentioned | GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1